Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 11, 2023 20:00 ET | Source: Origin Therapeutics Holdings Inc.

SAFE SUPPLY AND ORIGIN THERAPEUTICS RECEIVE CONDITIONAL APPROVAL FOR LISTING ON THE CSE

VANCOUVER, BC, CANADA, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Safe Supply Streaming Co. Ltd. (“Safe Supply” or the “Company”) and Origin Therapeutics Holdings Inc. (“Origin”) (CSE: ORIG) are pleased to...
September 05, 2023 15:57 ET | Source: Origin Therapeutics Holdings Inc.

Origin Therapeutics Announces Results of Annual General and Special Meeting of Shareholders

VANCOUVER, British Columbia, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (the “Company” or “Origin”) (CSE: ORIG) is pleased to announce that, in connection with the proposed...
August 02, 2023 12:01 ET | Source: Origin Therapeutics Holdings Inc.

SAFE SUPPLY AND ORIGIN THERAPEUTICS ANNOUNCE SIGNING OF DEFINITIVE AGREEMENT

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, BC, CANADA,...
August 02, 2023 11:58 ET | Source: Origin Therapeutics Holdings Inc.

Origin Therapeutics Announces Closing of Safe Supply Subscription Receipt Financing

Vancouver, British Columbia, Canada, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (“Origin” or the “Company”) is pleased to announce the closing of a private placement...
March 02, 2023 13:21 ET | Source: Origin Therapeutics Holdings Inc.

SAFE SUPPLY AND ORIGIN THERAPEUTICS ANNOUNCES ENGAGEMENT OF RESEARCH CAPITAL AND UPSIZING OF BROKERED FINANCING TO $4 MILLION

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, BC, CANADA,...
January 31, 2023 15:35 ET | Source: Origin Therapeutics Holdings Inc.

Origin Enters into Binding Letter of Intent with Safe Supply Streaming Co., a Pharmaceutical and Narcotics Investment Company with a First Mover Advantage in the Safe Supply Narcotics Sector

Vancouver, B.C., Jan. 31, 2023 (GLOBE NEWSWIRE) -- The completion of the transaction is anticipated to create the world’s first publicly-listed pharmaceutical and narcotics investment company...
October 31, 2022 19:00 ET | Source: Origin Therapeutics Holdings Inc.

Origin Therapeutics Announces New Director

Vancouver, B.C., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (CSE:ORIG) (the “Company” or “Origin Therapeutics”), announces the election of Jonathan Goldman as a new director...
October 18, 2022 18:00 ET | Source: Origin Therapeutics Holdings Inc.

Origin Therapeutics’ Portfolio Company, Clairvoyant, Approved for Phase 2 Psilocybin Therapy Trial; First Clinical Site Initiated in Finland

Vancouver, BC , Oct. 18, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (CSE: ORIG) (the “Company”, “Origin Therapeutics” or “Origin”), an actively managed, psychedelics industry-focused...
October 03, 2022 23:59 ET | Source: Origin Therapeutics Holdings Inc.

Origin Therapeutics Announces Director Resignation

Vancouver, B.C., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (CSE:ORIG) (the “Company” or “Origin Therapeutics”) announces that Michael Young has resigned as a director of...
September 22, 2022 11:42 ET | Source: Origin Therapeutics Holdings Inc.

Origin Therapeutics’ Portfolio Company, Xpira Pharmaceuticals, Receives FDA Approval For Psilocybin Trial IND Application

Toronto, ON, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (CSE: ORIG) (the “Company” or “Origin Therapeutics”), an actively managed, psychedelics industry-focused investment...